108 related articles for article (PubMed ID: 3266241)
1. [Study of head and neck cancer treatment by administration of autologous cytotoxic lymphocyte induced by stimulation with tumor cell--effect of adoptive immunotherapy by intra-arterial infusion of killer cells stimulated by autologous tumor in patients with maxillary carcinoma].
Eura M; Ikawa T; Ishikawa T; Fukiage T; Fukushima M; Samejima Y; Miyamura K
Nihon Jibiinkoka Gakkai Kaiho; 1988 Dec; 91(12):2069-78. PubMed ID: 3266241
[No Abstract] [Full Text] [Related]
2. [Study of head and neck cancer treatment by administration of autologous cytotoxic lymphocyte induced by stimulation with tumor cell--effect of adoptive immunotherapy by intra arterial infusion of killer cells stimulated by allogeneic tumor in patients with lingual and maxillary carcinoma].
Ishikawa T; Ikawa T; Eura M; Fukiage T; Arishima S; Yamasaki S; Kitao K; Uno K; Won N; Ohkubo Y
Nihon Jibiinkoka Gakkai Kaiho; 1988 Dec; 91(12):2082-8. PubMed ID: 3266243
[No Abstract] [Full Text] [Related]
3. [Adoptive immunotherapy by intra-arterial infusion of ATLAK or Allo-TLAK cells in patients with head and neck cancer].
Ikawa T; Eura M; Fukiage T; Murakami H; Yamasaki S; Fukuda K; Fukushima M; Arishima S; Maehara T; Ishikawa T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1438-47. PubMed ID: 2786378
[TBL] [Abstract][Full Text] [Related]
4. [Study of head and neck cancer treatment by administration of autologous cytotoxic lymphocyte induced by stimulation with tumor cell--induction of killer cells by stimulation with allogeneic tumor cell].
Ikawa T; Ishikawa T; Eura M
Nihon Jibiinkoka Gakkai Kaiho; 1988 Dec; 91(12):2079-81. PubMed ID: 3266242
[No Abstract] [Full Text] [Related]
5. Adoptive immunotherapy for head and neck cancer with killer cells induced by stimulation with autologous or allogeneic tumour cells and recombinant interleukin-2.
Ishikawa T; Ikawa T; Eura M; Fukiage T; Masuyama K
Acta Otolaryngol; 1989; 107(5-6):346-51. PubMed ID: 2787951
[TBL] [Abstract][Full Text] [Related]
6. [Bronchial arterial infusion of lymphokine-activated killer cells stimulated by autologous tumor cells].
Kimura H; Yamaguchi Y; Obata S; Yusa T; Sekine Y
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2401-4. PubMed ID: 3137876
[TBL] [Abstract][Full Text] [Related]
7. Autologous mixed lymphocyte-tumor reaction and autologous mixed lymphocyte reaction. II. Generation of specific and non-specific killer T cells capable of lysing autologous tumor.
Uchida A; Moore M; Klein E
Int J Cancer; 1988 May; 41(5):651-6. PubMed ID: 2966771
[TBL] [Abstract][Full Text] [Related]
8. Phorbol dibutyrate plus ionomycin improves the generation of cytotoxic T cells from draining lymph nodes of patients with advanced head and neck cancer.
McGrath PC; Hamby LS; Freeman JW
Am J Surg; 1992 Dec; 164(6):610-4. PubMed ID: 1463110
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a human cell line from maxillary squamous cell carcinoma and its biological features as a stimulator for induction of cytotoxic T lymphocytes.
Fukiage T; Chikamatsu K; Matsuoka H; Murakami H; Eura M; Masuyama K; Ishikawa T
Auris Nasus Larynx; 1994; 21(3):163-72. PubMed ID: 7872892
[TBL] [Abstract][Full Text] [Related]
10. [Induction of LAK cells and CTL in patients with brain tumor and research of its clinical application].
Moriki A
Nihon Geka Hokan; 1989 Jan; 58(1):107-18. PubMed ID: 2802908
[TBL] [Abstract][Full Text] [Related]
11. Induction of killer cells from lymphocytes in pleural effusion of advanced lung cancer patients.
Inoue Y; Shijubo N; Uede T
Jpn J Cancer Res; 1990 Oct; 81(10):1012-20. PubMed ID: 2172193
[TBL] [Abstract][Full Text] [Related]
12. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.
Yasumura S; Hirabayashi H; Schwartz DR; Toso JF; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1993 Mar; 53(6):1461-8. PubMed ID: 8443824
[TBL] [Abstract][Full Text] [Related]
13. [Fundamental and clinical aspects of adoptive immunotherapy with tumor-infiltrating lymphocytes].
Yahata G; Okada Y; Honda S; Tanaka K; Tokunaga A; Takahashi T; Seidou T; Takeuchi S
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1474-82. PubMed ID: 2471459
[TBL] [Abstract][Full Text] [Related]
14. [Clinical application of adoptive immunotherapy by cytotoxic T lymphocytes induced from tumor-infiltrating lymphocytes].
Yamaue H; Tanimura H; Tsunoda T; Iwahashi M; Tani M; Inoue M; Tamai M
Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):978-89. PubMed ID: 2391445
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effects of cytolytic T lymphocytes (CTL) and natural killer (NK) cells in head and neck cancer.
Whiteside TL; Chikamatsu K; Nagashima S; Okada K
Anticancer Res; 1996; 16(4C):2357-64. PubMed ID: 8816835
[TBL] [Abstract][Full Text] [Related]
16. Induction of ovarian tumor-specific CD8+ cytotoxic T lymphocytes by acid-eluted peptide-pulsed autologous dendritic cells.
Santin AD; Bellone S; Ravaggi A; Pecorelli S; Cannon MJ; Parham GP
Obstet Gynecol; 2000 Sep; 96(3):422-30. PubMed ID: 10960637
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of therapeutic potential of interleukin 2-expanded tumor-infiltrating lymphocytes in squamous cell carcinoma of the head and neck.
Boscia R; Chen K; Johnson JT; Whiteside TL
Ann Otol Rhinol Laryngol; 1988; 97(4 Pt 1):414-21. PubMed ID: 3261562
[TBL] [Abstract][Full Text] [Related]
18. [Basic and clinical study of adoptive immunotherapy using cytotoxic T lymphocyte (CTL) against cancers].
Kitsukawa K
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1448-54. PubMed ID: 2543306
[TBL] [Abstract][Full Text] [Related]
19. Production of lymphokine-activated lymphocytes. Lysis of human head and neck squamous cell carcinoma cell lines.
Alessi DM; Hutcherson RW; Mickel RA
Arch Otolaryngol Head Neck Surg; 1989 Jun; 115(6):725-30. PubMed ID: 2785809
[TBL] [Abstract][Full Text] [Related]
20. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
